Total Payments
$1.8M
2024 Payments
$274,215
Companies
28
Transactions
1,440
Medicare Patients
2,066
Medicare Billing
$604,247
Payment Breakdown by Category
Consulting$933,423 (51.6%)
Other$714,867 (39.5%)
Travel$123,985 (6.9%)
Food & Beverage$28,623 (1.6%)
Education$6,756 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $933,423 | 71 | 51.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $578,147 | 250 | 32.0% |
| Honoraria | $131,680 | 66 | 7.3% |
| Travel and Lodging | $123,985 | 506 | 6.9% |
| Food and Beverage | $28,623 | 528 | 1.6% |
| Education | $6,756 | 17 | 0.4% |
| Grant | $5,040 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Outset Medical Inc | $972,410 | 65 | $0 (2024) |
| Amgen Inc. | $274,899 | 373 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $175,731 | 168 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $137,762 | 240 | $0 (2024) |
| Relypsa, Inc. | $91,480 | 250 | $0 (2020) |
| BAXTER HEALTHCARE | $44,320 | 82 | $0 (2018) |
| CALLIDITAS THERAPEUTICS US INC. | $29,598 | 42 | $0 (2024) |
| Travere Therapeutics, Inc. | $28,356 | 64 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $18,720 | 8 | $0 (2022) |
| Vifor Pharma, Inc. | $11,884 | 44 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $274,215 | 382 | Amgen Inc. ($118,697) |
| 2023 | $209,993 | 229 | Amgen Inc. ($99,821) |
| 2022 | $240,358 | 197 | Outset Medical Inc ($97,010) |
| 2021 | $101,291 | 116 | Bayer HealthCare Pharmaceuticals Inc. ($28,771) |
| 2020 | $461,913 | 61 | Outset Medical Inc ($437,570) |
| 2019 | $156,923 | 183 | Outset Medical Inc ($87,611) |
| 2018 | $167,771 | 122 | Outset Medical Inc ($124,757) |
| 2017 | $195,189 | 150 | Outset Medical Inc ($128,363) |
All Payment Transactions
1,440 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Outset Medical Inc | — | Honoraria | Stock, stock option, or any other ownership interest | $11,798.29 | General |
| 12/30/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $23.32 | General |
| 12/27/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $224.75 | General |
| 12/20/2024 | Travere Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| 12/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: Diabetes | ||||||
| 12/19/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| Category: Nephrology | ||||||
| 12/19/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: Nephrology | ||||||
| 12/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $545.61 | General |
| Category: Cardio-renal | ||||||
| 12/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $265.57 | General |
| Category: Cardio-renal | ||||||
| 12/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $190.08 | General |
| Category: Cardio-renal | ||||||
| 12/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $115.81 | General |
| Category: Cardio-renal | ||||||
| 12/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $101.17 | General |
| Category: Cardio-renal | ||||||
| 12/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Cardio-renal | ||||||
| 12/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $7.00 | General |
| Category: Cardio-renal | ||||||
| 12/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $2.91 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $169.22 | General |
| Category: Nephrology | ||||||
| 12/11/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 12/11/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $92.11 | General |
| Category: Nephrology | ||||||
| 12/11/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $82.04 | General |
| Category: Nephrology | ||||||
| 12/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Rare Disease | ||||||
| 12/11/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $8.00 | General |
| Category: Nephrology | ||||||
| 12/09/2024 | Amgen Inc. | TAVNEOS (Drug) | Consulting Fee | Cash or cash equivalent | $1,761.58 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $1,000.00 | General |
| Category: Nephrology | ||||||
| 12/04/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $201.60 | General |
| Category: Nephrology | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 551 | 8,636 | $601,232 | $150,322 |
| 2022 | 9 | 520 | 1,048 | $454,243 | $137,788 |
| 2021 | 10 | 522 | 5,298 | $584,651 | $165,394 |
| 2020 | 9 | 473 | 7,040 | $637,453 | $150,743 |
Total Patients
2,066
Total Services
22,022
Medicare Billing
$604,247
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 181 | 316 | $115,024 | $35,922 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 169 | 329 | $81,263 | $26,963 | 33.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 23 | 87 | $84,564 | $23,664 | 28.0% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 24 | 120 | $90,840 | $22,757 | 25.1% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 16 | 7,560 | $151,200 | $17,804 | 11.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 79 | $38,631 | $13,452 | 34.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 47 | 47 | $17,155 | $4,518 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $14,958 | $4,224 | 28.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 71 | $7,597 | $1,018 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 158 | 281 | $99,193 | $32,515 | 32.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 30 | 104 | $96,720 | $28,507 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 161 | 336 | $80,640 | $27,088 | 33.6% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 29 | 141 | $102,084 | $26,684 | 26.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 56 | $26,600 | $9,750 | 36.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $17,754 | $4,848 | 27.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 36 | 36 | $12,744 | $3,838 | 30.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 31 | $11,098 | $2,758 | 24.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 30 | $7,410 | $1,799 | 24.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 169 | 339 | $116,277 | $39,686 | 34.1% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 37 | 140 | $130,200 | $38,668 | 29.7% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 34 | 163 | $118,012 | $31,191 | 26.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 128 | 207 | $48,231 | $16,823 | 34.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 40 | 70 | $32,270 | $12,124 | 37.6% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2021 | 16 | 4,244 | $80,636 | $10,911 | 13.5% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 16 | 23 | $26,151 | $7,644 | 29.2% |
About Dr. Luis Alvarez, MD
Dr. Luis Alvarez, MD is a Nephrology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487685368.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luis Alvarez, MD has received a total of $1.8M in payments from pharmaceutical and medical device companies, with $274,215 received in 2024. These payments were reported across 1,440 transactions from 28 companies. The most common payment nature is "Consulting Fee" ($933,423).
As a Medicare-enrolled provider, Alvarez has provided services to 2,066 Medicare beneficiaries, totaling 22,022 services with total Medicare billing of $604,247. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Palo Alto, CA
- Active Since 07/06/2006
- Last Updated 05/27/2020
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1487685368
Products in Payments
- TAVNEOS (Drug) $197,665
- Kerendia (Drug) $157,756
- Velphoro (Drug) $135,519
- Veltassa (Drug) $101,535
- Tavneos (Drug) $55,898
- Renal - Non Product Related (Biological) $33,549
- TARPEYO (Drug) $29,598
- Renal - Amia (Device) $10,712
- Crysvita (Drug) $9,082
- Auryxia (Drug) $4,290
- Fabhalta (Drug) $3,737
- JYNARQUE (Drug) $2,895
- LOKELMA (Drug) $2,623
- Aranesp (Biological) $223.16
- SOLIRIS (Drug) $213.41
- Parsabiv (Drug) $186.63
- LUPKYNIS (Drug) $156.34
- BENLYSTA (Biological) $143.50
- Impella (Device) $131.11
- FARXIGA (Drug) $117.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Palo Alto
Subramanian Sivarajan, M.d, M.D
Nephrology — Payments: $7,524
Nephrology $7,524
Timothy Meyer, Md, MD
Nephrology — Payments: $6,255
Nephrology $6,255
Graham Rodwell, Md, MD
Nephrology — Payments: $909.47
Nephrology $909.47
Ivie Okundaye, Md, MD
Nephrology — Payments: $580.56
Nephrology $580.56
Toby Gottheiner, Md, MD
Nephrology — Payments: $549.84
Nephrology $549.84
Nidharshan Anandasivam
Nephrology — Payments: $228.71
Nephrology $228.71